Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram, Aripiprazole, and Omega-3 for MDD with Anhedonia
NCT05389046Recruiting
- Sponsor
- Peking University
- Start
- Aug 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of aripiprazole and omega-3-acid triglycerides in major depressive disorder (MDD), sponsored by Peking University. Started Aug 2022; status: recruiting.
02
Drugs
aripiprazoleomega-3-acid triglycerides
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05389046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05389046.